DURECT

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DURECT and other ETFs, options, and stocks.

About DRRX

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator.

CEO

James E. Brown

CEOJames E. Brown

Employees

Employees79

Headquarters

Cupertino, California

HeadquartersCupertino, California

Founded

1998

Founded1998

Employees

Employees79

DRRX Key Statistics

Market cap

90.85M

Market cap90.85M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

238.48K

Average volume238.48K

High today

$0.434

High today$0.434

Low today

$0.39

Low today$0.39

Open price

$0.43

Open price$0.43

Volume

319.15K

Volume319.15K

52 Week high

$1.09

52 Week high$1.09

52 Week low

$0.3601

52 Week low$0.3601

DRRX Earnings

-$0.05

-$0.03

-$0.02

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 7, After Hours

ActualExpected Mar 7, After Hours

DURECT

Why Robinhood?

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. Show more

DRRX Key Statistics

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator.